A rare case of MRI of myxoid hepatocellular adenoma with gadoxetic acid uptake
Open Access
- 1 January 2023
- Vol. 9 (6) , 20230033
Abstract
This is the first case report of 43-year -old lady with a myxoid hepatic adenoma which demonstrated significant contrast uptake during hepatobiliary phase imaging. This highlights the potential for a missed diagnosis and likely subsequent malignant transformation in a young patient in whom it was initially presumed to be focal nodular hyperplasia with no further surveillance.Keywords
This publication has 11 references indexed in Scilit:
- Myxoid hepatocellular adenoma, a rare variant of hepatocellular adenoma with distinct imaging features: A case report with immunohistochemical and molecular analysis and literature reviewClinics and Research in Hepatology and Gastroenterology, 2021
- HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRIBMC Medical Imaging, 2021
- Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRIBritish Journal of Radiology, 2020
- Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?European Radiology, 2020
- Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesionsEuropean Radiology, 2018
- Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variantAbdominal Radiology, 2016
- Primary Hepatic Tumors With Myxoid ChangeAmerican Journal of Surgical Pathology, 2015
- MR Imaging of Hepatocellular Adenomas and Differential Diagnosis DilemmaInternational Journal of Hepatology, 2013
- Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid–enhanced MR Imaging in Differential DiagnosisRadiology, 2012
- Focal Nodular Hyperplasia: Findings at State-of-the-Art MR Imaging, US, CT, and Pathologic AnalysisRadioGraphics, 2004